-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O2N5XhM7kv1TDeQWXEpZp4DkwE00zMWZsFZ7R0Em5E5e1J584k34fAXGtgYDFITd QooeMddmYv1jTsQRx4SihQ== 0001104659-04-034242.txt : 20041108 0001104659-04-034242.hdr.sgml : 20041108 20041108145933 ACCESSION NUMBER: 0001104659-04-034242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041104 FILED AS OF DATE: 20041108 DATE AS OF CHANGE: 20041108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FREYMAN THOMAS C CENTRAL INDEX KEY: 0001239126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 041125420 BUSINESS ADDRESS: STREET 1: ABBOTT LABORATORIES STREET 2: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-6049 BUSINESS PHONE: 8479376100 4 1 a4.xml 4 X0202 4 2004-11-04 0 0000001800 ABBOTT LABORATORIES ABT 0001239126 FREYMAN THOMAS C 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive VP, Finance & CFO Common shares without par value 2004-11-04 4 M 0 2875 34.7727 A 179112 D Common shares without par value 2004-11-04 4 F 0 2292 43.61 D 176820 D Common shares without par value 16696 I Profit Sharing Trust Option (right to buy) 34.7727 2004-11-04 4 M 0 2875 0 D 2001-02-13 2008-02-12 common shares 2875 0 D Option (right to buy) 43.61 2004-11-04 4 A 0 2292 0 A 2005-05-05 2008-02-12 common shares 2292 2292 D Balance in the Abbott Laboratories Stock Retirement Trust as of November 4, 2004. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on January 22, 2004. John A. Berry, Attorney-in-Fact for Thomas C. Freyman 2004-11-08 -----END PRIVACY-ENHANCED MESSAGE-----